Published on 9/23/2005 in the Prospect News Biotech Daily.
New Issue: Acusphere prices $18.72 million follow on offering at $5.25, discounted from $5.93 close
By Ronda Fears
Nashville, Sept. 23 - Acusphere Inc. priced an offering of 3,566,000 shares of its common stock at $5.25 each, discounted from the close Thursday at $5.93, via bookrunner Piper Jaffray & Co.
Based in Watertown, Mass., Acusphere has three product candidates in clinical development in the areas of cardiology, oncology and asthma. Its lead candidate, AI-700, is in phase III clinical development for the detection of coronary artery disease.
Issuer: | Acusphere Inc.
|
Issue: | Follow-on stock offering
|
Gross proceeds: | $18,721,500
|
Net proceeds: | $17.5 million
|
Shares: | 3,566,000
|
Price: | $5.25 per share
|
Bookrunner: | Piper Jaffray & Co.
|
Pricing date: | Sept. 22
|
Settlement date: | Sept. 28
|
Ticker: | ACUS
|
Stock price: | $5.93 at close Sept. 22
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.